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Background
Breast cancer and cardiovascular disease are major public
health concerns worldwide. The two diseases are intri-
cately involved as treatment of one disease may lead to
detrimental effects in the other. Although the current
combination of surgical resection, radiotherapy, and
chemotherapy may lead to remission in breast cancer
patients, the administration of chemotherapeutic based
agents, in particular Doxorubicin, are associated with an
increased risk of cardiotoxicity. The introduction of novel
monoclonal antibodies in breast cancer therapy, includ-
ing Trastuzumab (Herceptin), which target growth factor
receptors, further compounds this issue of drug induced
cardiac dysfunction. Although serial multi gated acquisi-
tion scans (MUGA) are the conventional method for base-
line and serial assessment of left ventricular ejection
fraction (LVEF), little is known about the use of cardiac
MRI (CMR) in this clinical setting.
Objective
The aim of the current study was to assess the accuracy of
MUGA, 2D transthoracic echocardiography (TTE) and 3D
TTE in comparison to CMR in a breast cancer population
receiving doxorubicin and trastuzumab in the adjuvant
setting.
Methods
Between 2007-2009 inclusive, 50 female patients with
HER-2 positive breast cancer were identified to have
received adjuvant trastuzumab following doxorubicin at a
single tertiary care centre. Serial MUGA, 2D TTE, 3D TTE
and CMR were performed at baseline, 6 months and 12
months following the initiation of trastuzumab therapy in
all 50 patients.
Results
A comparison of left ventricular end systolic (LVESV) and
end diastolic volumes (LVEDV) demonstrated a modest
correlation between 2D TTE and CMR (r2 = 0.78 and r2 =
0.74 respectively). A comparison of LVESV and LVEDV
between 3D TTE and CMR demonstrated a stronger corre-
lation (r2 = 0.97 and r2 = 0.95). Although 2D TTE demon-
strated a weak correlation with CMR for LVEF assessment
(r2 = 0.58), both 3D TTE and MUGA showed a stronger
correlation when compared to CMR (r2 = 0.95) (Figures
1A and 1B).
Conclusion
As compared to conventional MUGA, CMR is a safe, accu-
rate and reproducible alternate imaging modality for the
serial monitoring of LVEF in breast cancer patients receiv-
ing chemotherapy.
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